NuVasive, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- J. Christopher Barry
- Full Time Employees
- 3,000
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 7475 Lusk Boulevard San Diego CA United States of America 92121
- IPO Date
- May 13, 2004
- CIK
- 0001142596
- Website
- nuvasive.com
- Similar Companies
- Business
- NuVasive, Inc., a medical technology enterprise, delivers comprehensive procedural solutions for spinal interventions. It offers advanced instruments for surgical access, such as sophisticated retraction systems that facilitate less-invasive techniques by minimizing soft tissue disruption during spinal operations. The company also provides a wide range of specialized spinal implants designed to enhance fusion through improved osseointegration and biomechanical properties of materials like porous titanium and advanced polyetheretherketone. Additionally, its fixation systems are engineered to help restore and maintain patient alignment. The company's portfolio includes innovative cervical total disc replacement technologies for spinal fusion, alongside neuromonitoring platforms that leverage proprietary software for nerve detection and avoidance, supported by extensive intraoperative monitoring services. Its Pulse technology, an integrated software ecosystem, consolidates multiple hardware systems into a single, efficient operating room footprint. Furthermore, NuVasive offers expandable rod implant systems for early-onset scoliosis treatment, a variety of biologics to aid in spinal fusion and bone healing, and specialized orthopedic devices like Precice, an intramedullary implant using MAGEC technology for non-invasive limb lengthening. The company also provides both onsite and remote neurological monitoring for patients undergoing spinal and cranial surgeries. NuVasive distributes its offerings to healthcare providers, surgeons, hospitals, and payers through a network of direct sales personnel, independent agents, and distributors across domestic and international markets. Established in 1997 and based in San Diego, California, NuVasive, Inc. became a subsidiary of Globus Medical, Inc. as of September 1, 2023.
Globus Medical: NuVasive Merger Unlocks Incremental NOPAT Growth
Why NuVasive (NUVA) is a Top Growth Stock for the Long-Term
NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting
Goosehead Insurance and Jackson Financial Set to Join S&P SmallCap 600
NuVasive (NUVA) Q2 Earnings Meet Estimates, Margins Down
NuVasive, Inc. (NUVA) Q2 2023 Earnings Call Transcript
NuVasive (NUVA) Q2 Earnings Meet Estimates
NuVasive Announces Second Quarter 2023 Financial Results
Radcliffe Capital Management, L.P. Acquires Stake in Portage Fintech Acquisition Corp
NuVasive Announces Conference Call and Webcast of Second Quarter 2023 Results
NuVasive (NUVA) Q1 Earnings Beat Estimates, Margins Fall
NuVasive, Inc. (NUVA) Q1 2023 Earnings Call Transcript
NuVasive (NUVA) Tops Q1 Earnings and Revenue Estimates
Globus Medical: Still Very Attractive After NuVasive Selloff
Is NuVasive (NUVA) a Great Value Stock Right Now?
NuVasive Shareholders Approve Merger Agreement with Globus Medical
New Strong Buy Stocks for April 26th
NUVA vs. ABT: Which Stock Is the Better Value Option?
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical
Leading Independent Proxy Advisory Firm ISS Recommends NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical